Alnylam Pharmaceuticals, Inc.
$295.51
USD
Last updated on --.
24h volume649.69K
24h highest301.09 USD
24h lowest294.26 USD
24h Price movement-0.65%
ALNY recent prices
24 Hours
-0.65%-$1.940
30 days
-3.59%-$11.07
60 days
-6.28%-$19.92
90 days
-9.14%-$29.92
Key data
Previous close297.45 USD
Market cap39.85B USD
Volume649.69K
P/E ratio69.040000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)4.3200 USD
Net income (FY)577.22M USD
Revenue (FY)4.29B USD
Last report date30 Apr 2026
About Alnylam Pharmaceuticals, Inc.
HeadquartersCAMBRIDGE
Employees (FY)2.50K
Revenue per employee (FY)1.71M USD
Net income per employee (FY)230.89K USD
Listed onNasdaq
ALNY conversion tables
 |  |
|---|---|
| 0.5 ALNY | 147.75 USD |
| 1 ALNY | 295.51 USD |
| 5 ALNY | 1,477.55 USD |
| 10 ALNY | 2,955.1 USD |
| |
|---|---|
| 0.5 USD | 0.001692 ALNY |
| 1 USD | 0.003384 ALNY |
| 5 USD | 0.01692 ALNY |
| 10 USD | 0.03384 ALNY |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ALNY is trading at $295.51, -0.65% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ALNY stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ALNY is currently trading at $295.51, -0.65% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ALNY price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ALNY's P/E ratio is currently 69.040000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ALNY; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ALNY's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Alnylam Pharmaceuticals, Inc.'s market cap is currently 39.85B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume649.69K
24h highest301.09 USD
24h lowest294.26 USD
24h Price movement-0.65%
Start trade with ALNY Perpetual
Sign up to trade